← All tickers

Is LXRX Worth Buying in 2026?

Lexicon Pharmaceuticals, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-04-19

Here’s whether Lexicon Pharmaceuticals, Inc. (LXRX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.60% over 10 days); RSI 65 — healthy momentum range; strong 1-year return of +274.0%; 3-month momentum positive (+36.5%). Currently 4.1% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

LXRX is in a confirmed uptrend, trading above both its 50-day ($1.57) and 200-day ($1.34) moving averages. An RSI of 64.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +274.0% compares to +35.1% for SPY (beat the market by 238.9%).

$10,000 invested 1 year ago → $37,400 today
vs. S&P 500 (SPY) — same period beat market by 238.9%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($1.34)
✓Above 50-day MA ($1.57)
✓RSI(14) neutral zone (30–70) — currently 64.9
✓Positive return (+274.0%)
✓Within 10% of period high (−4.1%)
Period Range $1.87
$0.48 $1.95
RSI (14) 64.9
0 · OversoldOverbought · 100

Key Metrics

Price$1.87
Period Return+274.0%
Period High$1.95
Period Low$0.48
Drawdown−4.1%
MA-50$1.57
MA-200$1.34
RSI (14)64.9
Avg Volume (30d)2.5M
vs. SPYbeat by 238.9%
Return Rank#71 of 996

Trade LXRX

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers